Sechenov School
Home › Pathophysiology › Type III Hypersensitivity Reactions

Type III Hypersensitivity Reactions

For medical students2 min readUpdated 2026-10-10

Type III hypersensitivity reactions (immune complex-mediated) occur when antigen-antibody-complement complexes form in the body. These precipitates deposit in tissues, causing severe immune-mediated inflammation and cellular damage.

SynonymsImmune complex-mediated reactions, precipitin reactions
AntibodiesPrecipitating immunoglobulins of the IgG and IgM classes
Main MechanismComplex formation: Antigen + Antibody + Complement factor
Core Damage MechanismThe complex initiates inflammation, increases vascular permeability, and causes microthrombosis

Etiology and Nature of Antigens

The primary triggers for Type III hypersensitivity reactions are soluble proteins. Pathology develops when these protein structures enter the body in excess amounts, are encountered repeatedly, or are continuously produced within the body itself.

Depending on their origin, antigens are divided into two major groups:

  1. Exogenous (external) antigens. These enter the body from the environment. They include therapeutic foreign sera and plasma, as well as vaccine solutions. Additionally, sources may include insect bites, inhalation of protein-containing substances, and infections with various microorganisms or fungi.
  2. Endogenous (internal) antigens. These form directly within the patient's tissues. This occurs during prolonged infectious processes, parasitic infestations (e.g., trypanosomiasis or helminthiasis), tumor growth, and paraproteinemias.

Pathogenesis: From Antigen Encounter to Inflammation

The development of precipitin reactions follows a strict five-stage sequence.

1. Immunological Phase Begins with the recognition of a soluble protein by macrophages. This is followed by complex cellular cooperation: the macrophage presents information to a T cell, which activates a B cell. Activated B cells differentiate into plasma cells and actively synthesize specialized antibodies—IgM and IgG.

2. Formation of Immune Complexes (ICs) Upon re-exposure to the same antigen, molecules bind together. The main feature of the synthesized immunoglobulins is their high propensity to precipitate upon contact with the antigen. The resulting structures are called immune complexes.

3. Sensitization Phase (Fate of the Complexes) These precipitates circulate via the blood and lymph throughout the body and subsequently deposit (settle) in various tissues and organs, leading to systemic sensitization.

4. Pathochemical Phase Fixation of ICs and activation of clearance mechanisms lead to the release of allergy mediators into the blood and tissues, with the complement cascade heavily involved.

5. Pathophysiological Phase (Tissue Damage) Mediators and the deposited complexes exert destructive effects on target tissues, causing direct cellular and non-cellular structural damage. Vascular permeability and basement membrane permeability increase dramatically. Severe immune-mediated inflammation is triggered, activating the coagulation cascade and leading to microthrombosis.

Clinical Manifestations

Disorders developing via the Type III mechanism are termed immune complex diseases. Their clinical presentation depends on the precise site of immune complex deposition.

If complexes form in the systemic circulation or lymph and disseminate to various organs, a systemic (generalized) form occurs. A classic example is serum sickness.

Major pathologies based on immune complex mechanisms include:

Mnemonic

Remember the key players of the damaging complex using the acronym AAC: Antigen + Antibody + Complement. This trio precipitates and triggers immune-mediated inflammation.

Frequently asked questions

What specific inflammatory mediators are released during the pathochemical phase of Type III hypersensitivity reactions?

During the pathochemical stage of Type III allergy, mediators appear in the blood and tissues due to the fixation of immune complexes and the activation of their clearance mechanisms. These include:

  • Leukotrienes and prostaglandins (PGs);
  • Chemoattractants and chemotactic factors;
  • Vasoactive agents and vasodilating proteins;
  • Procoagulants;
  • Lysosomal enzymes from phagocytes/neutrophils;
  • Reactive oxygen species (ROS), free radicals;
  • Complement components: C3a, C3b, C5a, as well as C4b, C2a, C5, C5b, C6, C7, and the membrane attack complex C5b-9;
  • Histamine, serotonin, kinins, TNF-α, Factor XII (Hageman factor), thromboxane A2.

Their reported effects include cell and extracellular matrix damage, induction of inflammation, increased vascular and basement membrane permeability, and activation of thrombosis.

Through which pathway is the complement system activated upon immune complex fixation?

Upon immune complex fixation, the complement system is activated via the classical (antibody-dependent) pathway.

  • Initiation — recognition of the antigen-antibody complex.
  • Binding — the C1q molecule interacts with the Fc fragment of the antibody (IgM or IgG) within the complex.
  • Active complex formation — attachment of C1r and C1s subunits leads to the formation of the C1qrs enzymatic complex.

This subsequently triggers a cascade of cleavage reactions for C4 and C2, culminating in the formation of the classical pathway C3 convertase and subsequent target lysis.

What chemotactic factors are generated by complement activation in Type III reactions?

During complement activation in immune complex reactions, the following chemotactic or chemotaxis-related components are generated:

  • C5 — chemotactic factor; associated with the migration of band neutrophils and monocytes.
  • C5a — ligand for the C5a receptor (C5aR) on neutrophils, monocytes, basophils, and eosinophils; function includes mediator release and chemotaxis.
  • C3a — ligand for the C3a receptor (C3aR) on mast cells, basophils, monocytes/macrophages, and neutrophils; function includes mediator release and chemotaxis.

These components participate in recruiting polymorphonuclear leukocytes to immune precipitates and their accumulation in vessel walls and perivascular spaces.

Which immunoglobulins participate in Type III reactions?

Precipitating antibodies of the IgG and IgM classes play the main role. Their key feature is the ability to form a precipitate upon contact with a soluble antigen.

What is the difference between local and systemic reactions?

The systemic form (e.g., serum sickness) develops when immune complexes circulate in the blood and deposit in multiple organs. The local form (Arthus phenomenon) occurs due to local formation and fixation of precipitates.

What occurs during the pathophysiological phase?

Immune-mediated inflammation develops: cells are damaged, vascular and basement membrane permeability increases, and microthrombus formation is activated.

Go deeper

More topics in Pathophysiology

Hyperosmolar ComaObesityHyponatraemiaBlood Buffer Systems: Anatomy, Parts and FunctionHypervitaminosis: Pathophysiology, Types and ToxicityClassification of HypoxiaChemical CarcinogensTypes of Substance Dependence and ToxicomaniaGeneral Adaptation SyndromeExtreme StatesHemorrhageAngina PectorisPathophysiology →